Jefferies Group LLC raised its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 89.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 85,196 shares of the company’s stock after acquiring an additional 40,109 shares during the period. Jefferies Group LLC’s holdings in Henry Schein were worth $5,953,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of HSIC. Advisor Group Inc. raised its stake in Henry Schein by 42.4% during the 4th quarter. Advisor Group Inc. now owns 6,837 shares of the company’s stock valued at $478,000 after purchasing an additional 2,036 shares during the period. Generation Investment Management LLP raised its stake in Henry Schein by 561.1% during the 4th quarter. Generation Investment Management LLP now owns 11,026,174 shares of the company’s stock valued at $770,509,000 after purchasing an additional 9,358,345 shares during the period. Rudman Errol M acquired a new stake in Henry Schein during the 4th quarter valued at $1,048,000. Renaissance Technologies LLC raised its stake in Henry Schein by 7,023.4% during the 4th quarter. Renaissance Technologies LLC now owns 627,712 shares of the company’s stock valued at $43,865,000 after purchasing an additional 618,900 shares during the period. Finally, Green Valley Investors LLC raised its stake in Henry Schein by 33.6% during the 4th quarter. Green Valley Investors LLC now owns 872,125 shares of the company’s stock valued at $60,944,000 after purchasing an additional 219,431 shares during the period. 97.62% of the stock is currently owned by institutional investors.
Several analysts have issued reports on HSIC shares. Morgan Stanley downgraded shares of Henry Schein from an “equal weight” rating to an “underweight” rating and set a $88.00 target price on the stock. in a research note on Wednesday, December 6th. Piper Jaffray Companies reissued a “buy” rating and set a $78.00 target price on shares of Henry Schein in a research note on Wednesday, December 27th. Credit Suisse Group reissued a “neutral” rating and set a $80.00 target price (down from $87.50) on shares of Henry Schein in a research note on Tuesday, November 28th. Zacks Investment Research raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, January 4th. Finally, Leerink Swann reissued a “hold” rating on shares of Henry Schein in a research note on Tuesday, February 13th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and eight have given a buy rating to the company’s stock. Henry Schein presently has an average rating of “Hold” and an average price target of $82.31.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 20th. The company reported $0.97 EPS for the quarter, meeting the consensus estimate of $0.97. Henry Schein had a net margin of 3.26% and a return on equity of 19.70%. The business had revenue of $3.32 billion for the quarter, compared to analysts’ expectations of $3.30 billion. During the same period in the previous year, the company posted $0.94 EPS. Henry Schein’s revenue was up 6.3% on a year-over-year basis. sell-side analysts predict that Henry Schein, Inc. will post 4.08 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Jefferies Group LLC Boosts Holdings in Henry Schein, Inc. (HSIC)” was first reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3253944/jefferies-group-llc-boosts-holdings-in-henry-schein-inc-hsic.html.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.